436 related articles for article (PubMed ID: 33299138)
1. Interactions between tumor-derived proteins and Toll-like receptors.
Jang GY; Lee JW; Kim YS; Lee SE; Han HD; Hong KJ; Kang TH; Park YM
Exp Mol Med; 2020 Dec; 52(12):1926-1935. PubMed ID: 33299138
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptors Signaling in the Tumor Microenvironment.
McCall KD; Muccioli M; Benencia F
Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
[TBL] [Abstract][Full Text] [Related]
3. Damage-associated molecular patterns in cancer: a double-edged sword.
Hernandez C; Huebener P; Schwabe RF
Oncogene; 2016 Nov; 35(46):5931-5941. PubMed ID: 27086930
[TBL] [Abstract][Full Text] [Related]
4. Untangling Local Pro-Inflammatory, Reparative, and Regulatory Damage-Associated Molecular-Patterns (DAMPs) Pathways to Improve Transplant Outcomes.
Dwyer GK; Turnquist HR
Front Immunol; 2021; 12():611910. PubMed ID: 33708206
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
Wicherska-Pawłowska K; Wróbel T; Rybka J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948194
[TBL] [Abstract][Full Text] [Related]
6. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection.
Urban-Wojciuk Z; Khan MM; Oyler BL; Fåhraeus R; Marek-Trzonkowska N; Nita-Lazar A; Hupp TR; Goodlett DR
Front Immunol; 2019; 10():2388. PubMed ID: 31695691
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
Dajon M; Iribarren K; Cremer I
Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
[TBL] [Abstract][Full Text] [Related]
8. Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases.
Li P; Chang M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299310
[TBL] [Abstract][Full Text] [Related]
9. Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth.
Zapletal E; Vasiljevic T; Busson P; Matijevic Glavan T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982351
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles and DAMPs in Cancer: A Mini-Review.
Abu N; Rus Bakarurraini NAA; Nasir SN
Front Immunol; 2021; 12():740548. PubMed ID: 34721407
[TBL] [Abstract][Full Text] [Related]
11. DAMP-TLR-cytokine axis dictates the fate of tumor.
Patidar A; Selvaraj S; Sarode A; Chauhan P; Chattopadhyay D; Saha B
Cytokine; 2018 Apr; 104():114-123. PubMed ID: 29032985
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Matrix-Derived Damage-Associated Molecular Patterns (DAMP): Implications in Systemic Sclerosis and Fibrosis.
Bale S; Verma P; Varga J; Bhattacharyya S
J Invest Dermatol; 2023 Oct; 143(10):1877-1885. PubMed ID: 37452808
[TBL] [Abstract][Full Text] [Related]
13. Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development.
Roedig H; Damiescu R; Zeng-Brouwers J; Kutija I; Trebicka J; Wygrecka M; Schaefer L
Semin Cancer Biol; 2020 May; 62():31-47. PubMed ID: 31412297
[TBL] [Abstract][Full Text] [Related]
14. DAMPs and NETs in Sepsis.
Denning NL; Aziz M; Gurien SD; Wang P
Front Immunol; 2019; 10():2536. PubMed ID: 31736963
[TBL] [Abstract][Full Text] [Related]
15. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
Sun L; Liu W; Zhang LJ
J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
[TBL] [Abstract][Full Text] [Related]
16. The Yin and Yang of Toll-like receptors in cancer.
Pradere JP; Dapito DH; Schwabe RF
Oncogene; 2014 Jul; 33(27):3485-95. PubMed ID: 23934186
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
Angrini M; Varthaman A; Cremer I
Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance.
Pandey S; Anang V; Schumacher MM
Int Rev Cell Mol Biol; 2024; 386():223-247. PubMed ID: 38782500
[TBL] [Abstract][Full Text] [Related]
19. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
[TBL] [Abstract][Full Text] [Related]
20. Insight into the mechanisms regulating immune homeostasis in health and disease.
Sirisinha S
Asian Pac J Allergy Immunol; 2011 Mar; 29(1):1-14. PubMed ID: 21560483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
